Citius Oncology, Inc. Ratios

Ratios Sep2024 Sep2025
Profitability
EBT Margin 10,871.99%
EBIT Margin 10,788.67%
EBITDA Margin 10,788.67%
Operating Margin 10,788.67%
Net Margin 11,356.76%
FCF Margin 2,518.92%
Leverage & Solvency
Interest Coverage Ratio -107.89
Times Interest Earned -107.89
Valuation
Enterprise Value 99.69M159.09M
Market Capitalization 99.69M159.09M
Return Ratios
Return on Sales 113.57%